42 related articles for article (PubMed ID: 22236547)
1. Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis.
Semino-Mora C; Liu H; McAvoy T; Nieroda C; Studeman K; Sardi A; Dubois A
Ann Surg Oncol; 2008 May; 15(5):1414-23. PubMed ID: 18299935
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).
Buyuk M; Ozluk Y; Bakkaloglu DV; Ozkan B; Firat P; Yilmazbayhan D
Turk Patoloji Derg; 2023; 39(1):64-74. PubMed ID: 36367122
[TBL] [Abstract][Full Text] [Related]
3. POFUT1 and PLAGL2 are characteristic markers of mucinous colorectal cancer associated with MUC2 expression.
Monno M; Ogiri M; Seishima R; Suzuki Y; Hattori K; Matsui S; Shigeta K; Okabayashi K; Kitagawa Y
Cell Biochem Funct; 2024 Mar; 42(2):e3989. PubMed ID: 38500386
[TBL] [Abstract][Full Text] [Related]
4. Extra-appendiceal mucinous neoplasms: A tumour with clinicopathologic similarities to low- and high-grade appendiceal counterpart.
Chen F; Harvey SE; Young ED; Liang TZ; Larman T; Voltaggio L
Hum Pathol; 2024 Apr; 148():23-31. PubMed ID: 38677555
[TBL] [Abstract][Full Text] [Related]
5. Bromelain and acetylcysteine (BromAc
Wen HK; Valle SJ; Morris DL
Am J Cancer Res; 2023; 13(4):1522-1532. PubMed ID: 37168359
[TBL] [Abstract][Full Text] [Related]
6. Regarding Blood-Based Next-Generation Sequencing Analysis of Appendiceal Cancers.
Shen JP
Oncologist; 2020 Dec; 25(12):e2019-e2020. PubMed ID: 33037839
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin.
Alakus H; Babicky ML; Ghosh P; Yost S; Jepsen K; Dai Y; Arias A; Samuels ML; Mose ES; Schwab RB; Peterson MR; Lowy AM; Frazer KA; Harismendy O
Genome Med; 2014; 6(5):43. PubMed ID: 24944587
[TBL] [Abstract][Full Text] [Related]
8. Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei.
Choudry HA; Mavanur A; O'Malley ME; Zeh HJ; Guo Z; Bartlett DL
Ann Surg Oncol; 2012 May; 19(5):1402-9. PubMed ID: 22302271
[TBL] [Abstract][Full Text] [Related]
9. Under the Hood: Understanding the Features of Mucin in Pseudomyxoma Peritonei.
Villarejo-Campos P; García-Arranz M; Qian S; Jiménez de Los Galanes S; Domínguez-Prieto V; Vélez-Pinto JF; Guijo Castellano I; Jiménez-Fuertes M; Guadalajara H; García-Olmo D
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373701
[TBL] [Abstract][Full Text] [Related]
10. High fat diet, gut microbiome and gastrointestinal cancer.
Tong Y; Gao H; Qi Q; Liu X; Li J; Gao J; Li P; Wang Y; Du L; Wang C
Theranostics; 2021; 11(12):5889-5910. PubMed ID: 33897888
[TBL] [Abstract][Full Text] [Related]
11. IL-19 Up-Regulates Mucin 5AC Production in Patients With Chronic Rhinosinusitis
Lai X; Li X; Chang L; Chen X; Huang Z; Bao H; Huang J; Yang L; Wu X; Wang Z; Bellanti JA; Zheng SG; Zhang G
Front Immunol; 2019; 10():1682. PubMed ID: 31379870
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of STAT3, ERK and estrogen-receptor α are associated with development and histologic severity of hepatic steatosis: a retrospective study.
Choi E; Kim W; Joo SK; Park S; Park JH; Kang YK; Jin SY; Chang MS
Diagn Pathol; 2018 Apr; 13(1):23. PubMed ID: 29615085
[TBL] [Abstract][Full Text] [Related]
13. Leptin receptor signaling is required for high-fat diet-induced atrophic gastritis in mice.
Inagaki-Ohara K; Okamoto S; Takagi K; Saito K; Arita S; Tang L; Hori T; Kataoka H; Matsumoto S; Minokoshi Y
Nutr Metab (Lond); 2016; 13():7. PubMed ID: 26839577
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: MUC3 is a novel prognostic factor.
Shibahara H; Higashi M; Yokoyama S; Rousseau K; Kitazono I; Osako M; Shirahama H; Tashiro Y; Kurumiya Y; Narita M; Kuze S; Hasagawa H; Kato T; Kubota H; Suzuki H; Arai T; Sakai Y; Yuasa N; Fujino M; Kondo S; Okamoto Y; Yamamoto T; Hiromatsu T; Sasaki E; Shirai K; Kawai S; Hattori K; Tsuji H; Okochi O; Sakamoto M; Kondo A; Konishi N; Batra SK; Yonezawa S
PLoS One; 2014; 9(12):e115613. PubMed ID: 25551773
[TBL] [Abstract][Full Text] [Related]
15. Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects.
Amini A; Masoumi-Moghaddam S; Ehteda A; Morris DL
Orphanet J Rare Dis; 2014 May; 9():71. PubMed ID: 24886459
[TBL] [Abstract][Full Text] [Related]
16. Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms.
Chang MS; Byeon SJ; Yoon SO; Kim BH; Lee HS; Kang GH; Kim WH; Park KJ
Pathobiology; 2012; 79(1):45-53. PubMed ID: 22236547
[TBL] [Abstract][Full Text] [Related]
17. MUC2 is a molecular marker for pseudomyxoma peritonei.
O'Connell JT; Hacker CM; Barsky SH
Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
[TBL] [Abstract][Full Text] [Related]
18. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour.
Stewart CJ; Tsukamoto T; Cooke B; Leung YC; Hammond IG
Pathology; 2006 Dec; 38(6):534-8. PubMed ID: 17393980
[TBL] [Abstract][Full Text] [Related]
19. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
